Developing Irreversible Inhibitors of the Protein Kinase Cysteinome

Slides:



Advertisements
Similar presentations
Pratistha Ranjitkar, Amanda M. Brock, Dustin J. Maly 
Advertisements

Discovery of Potent and Reversible Monoacylglycerol Lipase Inhibitors
Sweetly Expanding Enzymatic Glycodiversification
Ambiguous Origin: Two Sides of an Ephrin Receptor Tyrosine Kinase
Volume 17, Issue 1, Pages (January 2010)
Structural Basis for the Highly Selective Inhibition of MMP-13
Ross Alexander Robinson, Xin Lu, Edith Yvonne Jones, Christian Siebold 
Ready, Set, Cleave: Proteases in Action
Deubiquitination of Lys63-Linkage by a CYLD UBP
Ribosome Evolution for Two Artificial Amino Acids in E. coli
Arvin C. Dar, Michael S. Lopez, Kevan M. Shokat  Chemistry & Biology 
Matthieu Desroses, Mikael Altun  Cell Chemical Biology 
Volume 21, Issue 11, Pages (November 2014)
Adding Specificity to Artificial Transcription Activators
Deubiquitination of Lys63-Linkage by a CYLD UBP
Transcription: Identification of a prime suspect
Protein Kinase C Regulation: C1 Meets C-tail
Volume 19, Issue 7, Pages (July 2012)
Volume 14, Issue 12, Pages (December 2006)
Volume 17, Issue 8, Pages (August 2010)
MAP Kinase-Interacting Kinases—Emerging Targets against Cancer
Targeting the Undruggable Proteome: The Small Molecules of My Dreams
William J. Zuercher, Jonathan M. Elkins, Stefan Knapp 
Volume 14, Issue 5, Pages (May 2007)
Traffic Jam at the Bacterial Sec Translocase: Targeting the SecA Nanomotor by Small- Molecule Inhibitors  Kenneth Segers, Jozef Anné  Chemistry & Biology 
Adaptive Assembly: Maximizing the Potential of a Given Functional Peptide with a Tailor-Made Protein Scaffold  Hideki Watanabe, Shinya Honda  Chemistry.
Volume 13, Issue 10, Pages (October 2006)
Discovery of Potent and Reversible Monoacylglycerol Lipase Inhibitors
Volume 26, Issue 1, Pages e5 (January 2019)
Riboswitches: Fold and Function
Ins and Outs of Kinase DFG Motifs
Ross Alexander Robinson, Xin Lu, Edith Yvonne Jones, Christian Siebold 
Seisuke Yamashita, Kozo Tomita  Structure 
Ribosome Evolution for Two Artificial Amino Acids in E. coli
A General Strategy for Creating “Inactive-Conformation” Abl Inhibitors
A Structure-Guided Approach to Creating Covalent FGFR Inhibitors
Volume 15, Issue 9, Pages (September 2008)
Non-steroidal Anti-inflammatory Drugs Are Caspase Inhibitors
Making a New Turn In Matrix Metalloprotease Inhibition
Volume 26, Issue 2, Pages e4 (February 2018)
Sanjay B. Hari, Ethan A. Merritt, Dustin J. Maly  Chemistry & Biology 
Sachin Surade, Tom L. Blundell  Chemistry & Biology 
Volume 20, Issue 1, Pages (January 2013)
Volume 12, Issue 11, Pages (November 2005)
Volume 17, Issue 2, Pages (February 2010)
Volume 20, Issue 2, Pages (February 2013)
Structural Basis for the Highly Selective Inhibition of MMP-13
Volume 15, Issue 2, Pages (February 2007)
Breaking Down Order to Keep Cells Tidy
Volume 23, Issue 6, Pages (June 2015)
Volume 11, Issue 12, Pages (December 2003)
Conformation-Selective ATP-Competitive Inhibitors Control Regulatory Interactions and Noncatalytic Functions of Mitogen-Activated Protein Kinases  Sanjay B.
D. Grahame Hardie, Fiona A. Ross, Simon A. Hawley  Chemistry & Biology 
Volume 18, Issue 12, Pages (December 2011)
Inhibitor Specificity via Protein Dynamics
Pratistha Ranjitkar, Amanda M. Brock, Dustin J. Maly 
Ethan B. Butler, Yong Xiong, Jimin Wang, Scott A. Strobel 
Structural Basis of Swinholide A Binding to Actin
Volume 25, Issue 2, Pages e5 (February 2018)
Volume 21, Issue 9, Pages (September 2014)
Volume 20, Issue 2, Pages (February 2013)
Arvin C. Dar, Michael S. Lopez, Kevan M. Shokat  Chemistry & Biology 
Molecular Similarity Analysis Uncovers Heterogeneous Structure-Activity Relationships and Variable Activity Landscapes  Lisa Peltason, Jürgen Bajorath 
The Structure of JNK3 in Complex with Small Molecule Inhibitors
Allen R. Buskirk, David R. Liu  Chemistry & Biology 
A General Strategy for Creating “Inactive-Conformation” Abl Inhibitors
Peter Man-Un Ung, Rayees Rahman, Avner Schlessinger 
Volume 21, Issue 9, Pages (September 2014)
Ready, Set, Cleave: Proteases in Action
Volume 23, Issue 10, Pages (October 2016)
Presentation transcript:

Developing Irreversible Inhibitors of the Protein Kinase Cysteinome Qingsong Liu, Yogesh Sabnis, Zheng Zhao, Tinghu Zhang, Sara J. Buhrlage, Lyn H. Jones, Nathanael S. Gray  Chemistry & Biology  Volume 20, Issue 2, Pages 146-159 (February 2013) DOI: 10.1016/j.chembiol.2012.12.006 Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 1 Electrophiles Used in Irreversible Kinase Inhibitors Black balls represent other pharmacophore structures. Chemistry & Biology 2013 20, 146-159DOI: (10.1016/j.chembiol.2012.12.006) Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 2 Representative Chemical Structures of Reported Irreversible Protein Kinase Inhibitors Compounds were listed as reported names; those that do not have generic names are named in the order they are mentioned in the text. Chemistry & Biology 2013 20, 146-159DOI: (10.1016/j.chembiol.2012.12.006) Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 3 Representative Binding Modes of Irreversible Protein Kinase Inhibitors (A) ERK (PDB: 2E14), (B) EGFR (PDB: 2JIV), (C) BMX (modeling-based PDB: 3SXS), (D) EGFR(PDB: 3IKA), (E) VEGFR (modeling-based PDB: 1VR2), (F) RSK2 (modeling-based PDB: 2QR7), (G) BTK (modeling-based PDB: 3GEN), (H) KIT (modeling-based PDB:1T46), (I) JNK (PDB: 3V6S), (J) FGFR (PDB: 2FGI), (K) NEK2 (modeling-based PDB: 2JAV), (L) GSK3-β (modeling-based PDB: 1I09). Chemistry & Biology 2013 20, 146-159DOI: (10.1016/j.chembiol.2012.12.006) Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 4 Representative Positions of Accessible Cysteines in the Active Site 1YVJ, kinase domain used for depiction (cyan, staurosporine). The various colored circles indicate relative positions of Cys residues depicted on top of 1YVJ. Red, hinge region; yellow, gatekeeper and neighboring residues; blue, glycine loop closer to the ATP site; mauve, flexible region of glycine loop; green, activation loop (DFG area); orange, roof region. Chemistry & Biology 2013 20, 146-159DOI: (10.1016/j.chembiol.2012.12.006) Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 5 Distribution of the Cysteinome in the Kinome Tree Red dots represent kinases that have been proved to be targeted irreversibly by small molecule inhibitors. Chemistry & Biology 2013 20, 146-159DOI: (10.1016/j.chembiol.2012.12.006) Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 6 Schematic Representation of Reversible PKI Scaffold Base Approach to Develop Irreversible Inhibitors Chemistry & Biology 2013 20, 146-159DOI: (10.1016/j.chembiol.2012.12.006) Copyright © 2013 Elsevier Ltd Terms and Conditions

Figure 7 Schematic Representation of Flowchart for Profiling Data-Based Approach Chemistry & Biology 2013 20, 146-159DOI: (10.1016/j.chembiol.2012.12.006) Copyright © 2013 Elsevier Ltd Terms and Conditions